The medical grade polypropylene market is projected to grow from USD 5.2 billion in 2025 to USD 10.3 billion by 2035, at a CAGR of 7.1%. Homopolymer polypropylene will dominate with a 58.5% market share, while medical devices will lead the application outlook segment with a 30.8% share.